Nuvation Bio Inc. Class A Common Stock vs SK Hynix — how do they compare? Nuvation Bio Inc. Class A Common Stock trades at $5 (market cap $1.74B), while SK Hynix trades at $169.03 (market cap $891.31B). The key difference: SK Hynix is far larger — about 512.2× Nuvation Bio Inc. Class A Common Stock's market cap, and SK Hynix pays a 0.06% dividend while Nuvation Bio Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Nuvation Bio Inc. Class A Common Stock for 1 Days and SK Hynix for 10 Days on average.
| NUVB | SKHY | |
|---|---|---|
Market Cap | $1.74B | $891.31B |
Volume | 9,289,619 | 22,268,296 |
Sector | Health | Technology |
52-Week High | $9.54 | $198.63 |
52-Week Low | $3.41 | $126.79 |
Typical Hold Time | 1 Days | 10 Days |
Enterprise Value | $1.33B | $841.45B |
Dividend Yield | — | 0.06% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Nuvation Bio Inc. is a biopharmaceutical company focused on oncology, developing novel cancer treatments including taletrectinib (marketed as IBTROZI), a ROS1 inhibitor, and safusidenib, a brain-penetrant IDH1 inhibitor.
Read more on NUVB →SK hynix is a South Korean semiconductor company that manufactures memory products, including DRAM and NAND flash. Its high-bandwidth memory (HBM) products are designed for high-performance computing and AI applications.
Read more on SKHY →